94 research outputs found
The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
BACKGROUND: Zambia is facing a double crisis of increasing malaria burden and dwindling capacity to deal with the endemic malaria burden. The pursuit of sustainable but equity mechanisms for financing malaria programmes is a subject of crucial policy discussion. This requires that comprehensive accounting of the economic impact of the various malaria programmes. Information on the economic value of programmes is essential in soliciting appropriate funding allocations for malaria control. AIMS AND OBJECTIVES: This paper specifically seeks to elicit a measure of the economic benefits of an improved malaria treatment programme in Zambia. The paper also studies the equity implications in malaria treatment given that demand or malaria treatment is determined by household socio-economic status. METHODS: A contingent valuation survey of about 300 Zambian households was conducted in four districts. Willingness-to-pay (WTP) was elicited for an improved treatment programme for malaria in order to generate a measure of the economic benefits of the programme. The payment card method was used in eliciting WTP bids. FINDINGS: The study reports that malaria treatment has significant economic benefits to society. The total economic benefits of an improved treatment programme were estimated at an equivalent of US$ 77 million per annum, representing about 1.8% of Zambia's GDP. The study also reports the theoretically anticipated association between WTP and several socio-economic factors. Our income elasticity of demand is positive and similar in magnitude to estimates reported in similar studies. Finally, from an equity standpoint, the constraints imposed by income and socio-economic status are discussed
Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia
BACKGROUND:Malaria in Zambia accounts for about 4 million clinical cases and 8 000 deaths annually. Artemether-lumefantrine (ACT), a relatively expensive drug, is being used as first line treatment of uncomplicated malaria. However, diagnostic capacity in Zambia is low, leading to potentially avoidable wastage of drugs due to unnecessary anti malarial treatment. METHODS: A cost-effectiveness evaluation of the three current alternatives to malaria diagnosis (clinical, microscopy and Rapid Diagnostic Tests- RDT) was conducted in 12 facilities from 4 districts in Zambia. The analysis was conducted along an observational study, thus reflecting practice in health facilities under routine conditions. Average and incremental cost effectiveness ratios were estimated from the providers' perspective. Effectiveness was measured in relation to malaria cases correctly diagnosed by each strategy. RESULTS: Average cost-effectiveness ratios show that RDTs were more efficient (US 11.9) or clinical diagnosis (US 2.6 and US$ 9.6 for RDT and microscopy respectively. RDTs would be much cheaper to scale up than microscopy. The findings were robust to changes in assumptions and various parameters. CONCLUSION: RDTs were the most cost effective method at correctly diagnosing malaria in primary health facilities in Zambia when compared to clinical and microscopy strategies. However, the treatment prescription practices of the health workers can impact on the potential that a diagnostic test has to lead to savings on antimalarials. The results of this study will serve to inform policy makers on which alternatives will be most efficient in reducing malaria misdiagnosis by taking into account both the costs and effects of each strategy
Determinants of Child Nutritional Status in Zambia: An Analysis of a National Survey
Malnutrition affects many children and is a leading cause of childhood mortality and non-fatal health loss. Zambia has one of the highest rates of malnutrition in the world. About half of the Zambian children are stunted while one in five is underweight. Prevalence of wasting is much lower. This article examines the determinants of nutritional status among children aged below five years in Zambia using data from a national cross-sectional survey conducted in 2006. Multivariate analysis is used to quantify the effects of several household and child-specific socioeconomic and demographic factors on nutritional status, as well as a geographic context (community level) fixed effect. Our analysis indicates that household expenditure is a leading determinant of nutritional status of a child. Further, the positive effect of parental education was observed. Children become more malnourished as they get older than 18 months. Poor nutrition falls disproportionately on rural children, after all other included covariates were controlled for. The significance of the geographic context suggests an underlying ecological pattern to malnutrition besides the individual and households factors. Understanding the determinants of poor nutritional attainment can provide insights in designing interventions for reducing the high levels of child malnutrition in Zambia
Determinants of Healthcare Utilisation and Out-ofPocket Payments in the Context of Free Public Primary Healthcare in Zambia
Background: Access to appropriate and affordable healthcare is needed to achieve better health outcomes in Africa.
However, access to healthcare remains low, especially among the poor. In Zambia, poor access exists despite the policy
by the government to remove user fees in all primary healthcare facilities in the public sector. The paper has two
main objectives: (i) to examine the factors associated with healthcare choices among sick people, and (ii) to assess the
determinants of the magnitude of out-of-pocket (OOP) payments related to a visit to a health provider.
Methods: This paper employs a multilevel multinomial logistic regression to model the determinants of an individual’s
choice of healthcare options following an illness. Further, the study analyses the drivers of the magnitude of OOP
expenditure related to a visit to a health provider using a two-part generalised linear model. The analysis is based on a
nationally representative healthcare utilisation and expenditure survey that was conducted in 2014.
Results: Household per capita consumption expenditure is significantly associated with increased odds of seeking
formal care (odds ratio [OR]=1.12, P=.000). Living in a household in which the head has a higher level of education is
associated with increased odds of seeking formal healthcare (OR=1.54, P=.000) and (OR=1.55, P=.01), for secondary
and tertiary education, respectively. Rural residence is associated with reduced odds of seeking formal care (OR=0.706,
P=.002). The magnitude of OOP expenditure during a visit is significantly dependent on household economic wellbeing, distance from a health facility, among other factors. A 10% increase in per capita consumption expenditure was
associated with a 0.2% increase in OOP health expenditure while every kilometre travelled was associated with a K0.51
increase in OOP health expenditure.
Conclusion: Despite the removal of user fees on public primary healthcare in Zambia, access to healthcare is highly
dependent on an individual’s socio-economic status, illness type and region of residence. These findings also suggest that
the benefits of free public healthcare may not reach the poorest proportionately, which raise implications for increasing
access in Zambia and other countries in sub-Saharan Africa
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
BACKGROUND: Malaria remains a leading cause of morbidity, mortality and non-fatal disability in Zambia, especially among children, pregnant women and the poor. Data gathered by the National Malaria Control Centre has shown that recently observed widespread treatment failure of SP and chloroquine precipitated a surge in malaria-related morbidity and mortality. As a result, the Government has recently replaced chloroquine and SP with combination therapy as first-line treatment for malaria. Despite the acclaimed therapeutic advantages of ACTs over monotherapies with SP and CQ, the cost of ACTs is much greater, raising concerns about affordability in many poor countries such as Zambia. This study evaluates the cost-effectiveness analysis of artemether-lumefantrine, a version of ACTs adopted in Zambia in mid 2004. METHODS: Using data gathered from patients presenting at public health facilities with suspected malaria, the costs and effects of using ACTs versus SP as first-line treatment for malaria were estimated. The study was conducted in six district sites. Treatment success and reduction in demand for second line treatment constituted the main effectiveness outcomes. The study gathered data on the efficacy of, and compliance to, AL and SP treatment from a random sample of patients. Costs are based on estimated drug, labour, operational and capital inputs. Drug costs were based on dosages and unit prices provided by the Ministry of Health and the manufacturer (Norvatis). FINDINGS: The results suggest that AL produces successful treatment at less cost than SP, implying that AL is more cost-effective. While it is acknowledged that implementing national ACT program will require considerable resources, the study demonstrates that the health gains (treatment success) from every dollar spent are significantly greater if AL is used rather than SP. The incremental cost-effectiveness ratio is estimated to be US$4.10. When the costs of second line treatment are considered the ICER of AL becomes negative, indicating that there are greater resource savings associated with AL in terms of reduction of costs of complicated malaria treatment. CONCLUSION: This study suggests the decision to adopt AL is justifiable on both economic and public health grounds
Patient satisfaction and perceived quality of care: evidence from a cross-sectional national exit survey of HIV and non-HIV service users in Zambia
ObjectiveTo examine the associations between perceived quality of care and patient satisfaction among HIV and non-HIV patients in Zambia.SettingPatient exit survey conducted at 104 primary, secondary and tertiary health clinics across 16 Zambian districts.Participants2789 exiting patients.Primary independent variablesFive dimensions of perceived quality of care (health personnel practice and conduct, adequacy of resources and services, healthcare delivery, accessibility of care, and cost of care).Secondary independent variablesRespondent, visit-related, and facility characteristics.Primary outcome measurePatient satisfaction measured on a 1–10 scale.MethodsIndices of perceived quality of care were modelled using principal component analysis. Statistical associations between perceived quality of care and patient satisfaction were examined using random-effect ordered logistic regression models, adjusting for demographic, socioeconomic, visit and facility characteristics.ResultsAverage satisfaction was 6.9 on a 10-point scale for non-HIV services and 7.3 for HIV services. Favourable perceptions of health personnel conduct were associated with higher odds of overall satisfaction for non-HIV (OR=3.53, 95% CI 2.34 to 5.33) and HIV (OR=11.00, 95% CI 3.97 to 30.51) visits. Better perceptions of resources and services were also associated with higher odds of satisfaction for both non-HIV (OR=1.66, 95% CI 1.08 to 2.55) and HIV (OR=4.68, 95% CI 1.81 to 12.10) visits. Two additional dimensions of perceived quality of care—healthcare delivery and accessibility of care—were positively associated with higher satisfaction for non-HIV patients. The odds of overall satisfaction were lower in rural facilities for non-HIV patients (OR 0.69; 95% CI 0.48 to 0.99) and HIV patients (OR=0.26, 95% CI 0.16 to 0.41). For non-HIV patients, the odds of satisfaction were greater in hospitals compared with health centres/posts (OR 1.78; 95% CI 1.27 to 2.48) and lower at publicly-managed facilities (OR=0.41, 95% CI=0.27 to 0.64).ConclusionsPerceived quality of care is an important driver of patient satisfaction with health service delivery in Zambia
Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
INTRODUCTION: Antiretroviral therapy (ART) guidelines were significantly changed by the World Health Organization in 2010. It is largely unknown to what extent these guidelines were adopted into clinical practice. METHODS: This was a retrospective observational analysis of first-line ART regimens in a sample of health facilities providing ART in Kenya, Uganda, and Zambia between 2007-2008 and 2011-2012. Data were analyzed for changes in regimen over time and assessed for key patient- and facility-level determinants of tenofovir (TDF) utilization in Kenya and Uganda using a mixed effects model. RESULTS: Data were obtained from 29,507 patients from 146 facilities. The overall percentage of patients initiated on TDF-based therapy increased between 2007-2008 and 2011-2012 from 3% to 37% in Kenya, 2% to 34% in Uganda, and 64% to 87% in Zambia. A simultaneous decrease in stavudine (d4T) utilization was also noted, but its use was not eliminated, and there remained significant variation in facility prescribing patterns. For patients initiating ART in 2011-2012, we found increased odds of TDF use with more advanced disease at initiation in both Kenya (odds ratio [OR]: 2.78; 95% confidence interval [CI]: 1.73-4.48) and Uganda (OR: 2.15; 95% CI: 1.46-3.17). Having a CD4 test performed at initiation was also a significant predictor in Uganda (OR: 1.43; 95% CI: 1.16-1.76). No facility-level determinants of TDF utilization were seen in Kenya, but private facilities (OR: 2.86; 95% CI: 1.45-5.66) and those employing a doctor (OR: 2.86; 95% CI: 1.48-5.51) were more likely to initiate patients on TDF in Uganda. DISCUSSION: d4T-based ART has largely been phased out over the study period. However, significant in-country and cross-country variation exists. Among the most recently initiated patients, those with more advanced disease at initiation were most likely to start TDF-based treatment. No facility-level determinants were consistent across countries to explain the observed facility-level variation
The adult prevalence of HIV in Zambia: results from a population based mobile testing survey conducted in 2013–2014
- …